We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biosensor System Developed for Blood Glucose Monitoring

By LabMedica International staff writers
Posted on 11 Jan 2018
Print article
Image: The skin-like biosensor system developed for noninvasive blood glucose monitoring (Photo courtesy of Tsinghua University).
Image: The skin-like biosensor system developed for noninvasive blood glucose monitoring (Photo courtesy of Tsinghua University).
Currently, noninvasive glucose monitoring is not widely appreciated because of its uncertain measurement, accuracy, weak blood glucose correlation and inability to detect hyperglycemia/hypoglycemia during sleep.

Regulated and continuous glucose monitoring (CGM) of diabetes patients can provide better monitoring and control of blood glucose and prevent complications and glucose monitoring with commercially available products relies on invasive lancet approaches.

Scientists at the Tsinghua University (Beijing, China) fabricated a skin-like biosensor system for noninvasive, in situ, and highly accurate intravascular blood glucose monitoring. The system integrates an ultrathin skin-like biosensor with paper battery–powered electrochemical twin channels (ETCs). The designed subcutaneous ETCs drive intravascular blood glucose out of the vessel and transport it to the skin surface.

The ultrathin (~3 μm) nanostructured biosensor, with high sensitivity (130.4 μA/mM), fully absorbs and measures the glucose, owing to its extreme conformability. The ultrathin skin-like biosensors completely conform to the skin and measure the outward-transported glucose driven by ETCs. These biosensors are multilayered with “sand dune” nanostructures, which exhibit better electrochemical properties and higher sensitivity.

The team conducted in vivo human clinical trials. Invasive glucose measurement was done using a commercial glucometer and vein-detained needles. The skin-like noninvasive blood glucose monitoring system measured the intravascular blood glucose and the glucose in interstitial fluid (ISF). The ETCs greatly improve the correlation between the noninvasive measurement results and the real blood glucose level. With proper calibration, the system is potentially suitable for medical-grade CGM and insulin therapy when working with micro-insulin pumps. The study was published on December 1, 2017, in the journal Science Advances.

Related Links:
Tsinghua University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.